April 5 – UCB SA:
* UCB STRENGTHENS RESEARCH CAPABILITIES WITH ACQUISITION OF ELEMENT GENOMICS, A DUKE UNIVERSITY BIOTECH SPIN-OFF
* TOTAL COST OF TRANSACTION WILL AMOUNT TO UP TO USD 30 MILLION
* ELEMENT GENOMICS’ TEAM WILL CONTINUE TO BE BASED IN DOWNTOWN DURHAM, WILL WORK CLOSELY WITH UCB’S RESEARCH TEAMS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Recent Posts
- List of Top 10 Health Tech Companies in 2025 in London, UK, Europe, Asia (India, China, Japan), Saudi Arabia, UAE, USA, and Germany.
- List of Top Healthcare Exhibitions 2024-2025 in London, UK, Europe, Asia, and the USA
- A Review of Top 10 Digital Health Market Size Reports: 2024, 2025, and 2030 in the UK, Europe, Asia, USA, Middle East, and Saudi Arabia
- Digital Health Visionary Alan Spiro Joins Laguna Health
- Siemens Healthineers, Geisinger ink 10-year digital health partnership
- NHSX launches Tech Plan to consult on what the unit should be doing
- Stanford Medicine’s 2020 Health Trends Report spotlights the rise of the data-driven physician
- Saudi Arabian wealth fund to invest in digital health startup Babylon
- Siemens Healthineers and Mentice Bring a Virtual Patient to the Angio-suite
- NHS Launches Digital Health Unit: NHSX